VC
FOMX

Vivo Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Vivo Capital’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-201,478
Closed -$723K – 51
2018
Q4 		$723K Sell
201,478
-226,022
-53% -$983K 0.09% 42
2018
Q3 		$2.45M Sell
427,500
-427,500
-50% -$2.45M 0.25% 39
2018
Q2 		$4.28M Hold
855,000
– – 0.55% 31
2018
Q1 		$4.39M Hold
855,000
– – 0.62% 25
2017
Q4 		$5.14M Hold
855,000
– – 1.1% 21
2017
Q3 		$4.75M Hold
855,000
– – 0.96% 20
2017
Q2 		$3.97M Hold
855,000
– – 1% 17
2017
Q1 		$4.23M Hold
855,000
– – 1.24% 15
2016
Q4 		$9.49M Hold
855,000
– – 3.13% 9
2016
Q3 		$7.92M Buy
+855,000
New +$7.15M 2.47% 12

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Vivo Capital's FOMX Position: Q1 2019 in Review

Vivo Capital sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2019, closing a stake of 201,478 shares — an estimated $723K sold.

Vivo Capital first reported a position in FOMX in Q3 2016 and held it in 10 quarters. The position peaked at $9.49M in Q4 2016. 62 funds tracked by Wall St. Rank hold FOMX as of Q1 2019.

  • Vivo Capital reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Vivo Capital sold 201,478 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2019, an estimated $723K.
  • Vivo Capital first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2016 and held it in 10 quarters.
  • Vivo Capital's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $9.49M in Q4 2016.
  • 62 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2019.

Based on Vivo Capital's 13F filing for Q1 2019, filed 14 May 2019.